Search All News
This July, Columbia neurologist Mitch Elkind will become president of the American Heart Association, only the second time a neurologist has led the organization.
Patients taking the recommended diuretic for hypertension experienced more potentially serious side effects than those taking a similar drug, according to a new study from Columbia researchers.
- January 24, 2018
Clinical trial shows that solanezumab, an antibody-based treatment for Alzheimer’s disease, does not significantly slow cognitive decline.
- January 16, 2018
Columbia neurologists and engineers are using a robotic device to investigate how Parkinson’s affects the ability to walk and respond to balance perturbations.
- November 22, 2017
New video that reveals how immune cells breach the blood-brain barrier is giving scientists new ideas about treating multiple sclerosis.
- November 17, 2017
Researchers at Columbia University found that dementia is on the decline in seniors from northern Manhattan, following national trends.
- November 13, 2017
A new study suggests a smell test can identify people with mild cognitive impairment–often a precursor to Alzheimer’s–who may benefit from cholinesterase inhibitors.
- November 8, 2017
New Zika research from Columbia University suggests that high rates of microcephaly in Brazil were not caused by new mutations in the virus, as previously believed.
- October 3, 2017
Scientists propose a new model for Alzheimer's disease that may explain the high failure rate of recent clinical trials.
- September 18, 2017
A cellular defense against protein aggregates suppresses ALS in early stages but later hastens spread of the disease, a study in mice suggests.